Romania’s Simona Halep rounded on the International Tennis Integrity Agency (ITIA) for discrepancies in the treatment of world No. 2 Iga Swiatek after testing positive for a banned substance. The ITIA announced a one-month ban on Thursday for Swiatek after the 23-year-old had tested positive for the heart medication trimetazidine (TMZ) in an out-of-competition sample in August 2024, when the Polish player was ranked number one in the world, according to Daily Tribune.
Halep, now 33, returned to tennis in March this year after her own career had been on hold since 7 October 2022, the date of the start of her provisional suspension after testing positive for roxadustat at the US Open.
The winner of the 2018 French Open and 2019 Wimbledon singles titles was then caught up in a second affair, this time “irregularities” in the data of her biological passport.
She was handed a four-year ban by the ITIA, but Halep successfully appealed to the Court of Arbitration for Sport (CAS) in February, arguing her positive test for roxadustat — used to treat anaemia and banned as a blood doping agent — was the result of a tainted supplement.
Read more at: https://tribune.net.ph/2024/11/30/halep-rips-doping-body-for-discrepancies
Read more Daily Tribune stories at: https://tribune.net.ph/
Photo: Facebook/Simona Halep
